Teva Pharmaceutical Industries (TEVA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec30

Oak Harvest Investment Services Acquires 50,000 Shares of Teva Pharmaceutical

12:12

Dec24

Teva's Credit Rating Upgraded by S&P, Moody's Outlook Revised to Positive

13:36

Dec22

Teva Pharmaceuticals Reaches New 52-Week High with Raised Target Price

15:44

Teva Pharmaceutical Industries Upgraded by Analysts

12:22

Dec19

Teva's CFO Sells Company Shares

15:15

Alvotech and Teva Reach Settlement with Regeneron for AVT06 US Launch

08:32

Schedules & Filings

Schedules

Filings

Jan28

Earning Release(EST)

FY2025 Q4 Earning Release

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.48 B, Net Income 433 M, EPS 0.37

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.176 B, Net Income 282 M, EPS 0.24

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change